Abstract
Harmonization of procedures for the approval of medicines in the WAEMU area allows Member States to have astandard tool for the examination of applications for marketing authorization for medicinal products for human use.The objective of this study was to highlight the textual provisions adopted by a member state, Côte d'Ivoire foroptimal application of the Community norm. The methodology used consisted, on the basis of a reminder of the mainpoints of Regulation No. 06 / CM / UEMOA concerning the approval of medicinal products for human use, to showhow the national implementing decrees taken in Côte d'Ivoire the Regulation. However, the need for Member Statesto act more expeditiously with regard to the application of Community standards is clear. 
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
